Professor M. Suematsu gave a lecture to KU community – Imaging Metabolomics in Humanized Experimental Platforms: Translation to Control Cancer and Neurodegenerative Diseases. The areas of his research interest include oncology, metabolic imaging of malignancies, genetics, diagnostics of rare diseases, metabolomics, etc.
“Professor Makoto Suematsu pays special attention to the cooperation between Japan and Lithuania in the field of medicine and medical research. During the meeting, Professor shared his valuable knowledge, we talked more about the research conducted by the scientists of the Faculty of Health Sciences, and presented the activities as well as research of Klaipėda University Hospital. We see the potential and benefits of mutual cooperation,” said Prof. Dr. Artūras Razbadauskas, Rector of KU.
Prof. Dr. Artūras Razbadauskas, Rector of KU, presented to the guests the University, its structure, study programs, the EU-CONEXUS Alliance, and laboratories. The main focus was on the Faculty of Health Sciences and the research carried out by its scientists. Issues and opportunities for mutual cooperation were also discussed.
The meeting and discussions were also attended by Dr. Reda Dzingelevičienė, Head of KU Centre for Postgraduate Medical Studies, Assoc. Prof. Dr. Vytenis Punys, Head of KU Department of Medical Technologies, Dr. Audrius Šimaitis, General Manager of Klaipėda University Hospital, Prof. Dr. Antanas Gulbinas, Director of Medical Affairs at KUH, and Prof. Dr. Linas Venclauskas, Head of Clinic of Surgery at KUH.
The visit included a tour around KU Methodological STEAM Centre and the Marine Research Institute. Other meetings were held at Klaipėda University Hospital.
Lithuania and Japan have been cooperating in the biomedical field since 2017, when representatives of the Ministry of Health of Lithuania and the Japan Agency for Medical Research and Development (AMED) signed a Memorandum of Understanding. In this document, the countries agreed on joint research projects, conferences, and seminars. The countries are also encouraged to cooperate on research into rare diseases and exchange best practices.
